middle.news
Rhythm Biosciences Raises $3.75M to Launch ColoSTAT® and Expand geneType™
9:43am on Monday 18th of August, 2025 AEST
•
Healthcare
Read Story
Rhythm Biosciences Raises $3.75M to Launch ColoSTAT® and Expand geneType™
9:43am on Monday 18th of August, 2025 AEST
Key Points
Placement to raise up to $3.75 million via ~41.6 million new shares at $0.09 each
New shares represent a 14.7% dilution of existing capital
Funds earmarked for ColoSTAT® commercial launch and geneType™ market expansion
Directors to participate subject to 2025 AGM approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE